Over-the-counter drug · OTC MONOGRAPH DRUG
Proctozone-B (Bisacodyl) NDC 57237-337
Bisacodyl 10 mg/1 · Suppository · Rectal · Rising Pharma Holdings, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 57237-337-03 | 5723703370357237033703 | 6 BLISTER PACK in 1 CARTON (57237-337-03) / 5 SUPPOSITORY in 1 BLISTER PACK (57237-337-51)Marketed from Feb 1, 2025 | |
| 57237-337-21 | 5723703372157237033721 | 3 BLISTER PACK in 1 CARTON (57237-337-21) / 4 SUPPOSITORY in 1 BLISTER PACK (57237-337-04)Marketed from Dec 1, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Proctozone-B
- Generic name (nonproprietary)
- bisacodyl
- Active ingredients
- Bisacodyl — 10 mg/1
- Dosage form
- Suppository
- Route
- Rectal
- Labeler
- Rising Pharma Holdings, Inc.NDC labeler code 57237
- Product type
- Over-the-counter drug
- Marketing category
- OTC monograph drugApplication M007.60
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
- Identifiers
- Product ID 57237-337_ad7d1357-40a1-47d3-bb30-77aaf1547659SPL ID ad7d1357-40a1-47d3-bb30-77aaf1547659SPL set ID c53ed934-3846-4dc8-b97b-c84171c21ae1RxCUI 198509UNII 10X0709Y6I
- Pharmacologic class
- Stimulant Laxative
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N457237033703followed by a unit qualifier and the quantityPackage 57237-0337-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Use for relief of occasional constipation (irregularity) this product generally produces bowel movement in 15 minutes to 1 hour
Excerpt only. Read the full label for complete information.
About NDC 57237-337
- What is NDC 57237-337?
- 57237-337 is the product NDC for Proctozone-B (bisacodyl), Bisacodyl 10 mg/1 suppository, listed with the FDA by Rising Pharma Holdings, Inc.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Proctozone-B (Bisacodyl).
- What is the active ingredient?
- Bisacodyl.
- Who is the labeler?
- Rising Pharma Holdings, Inc., NDC labeler code 57237. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Proctozone-B?
- 1 other product NDC are listed under this name. See all Proctozone-B NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Proctozone-B products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Proctozone-Bbisacodyl | Bisacodyl 5 mg/1 | Tablet, CoatedOral | Rising Pharma Holdings, Inc. | 57237-372 | 57237-0372-01 |
Other NDCs under M007.60
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Senna Syrupsennosides | Sennosides 8.8 mg/5mL | LiquidOral | Rising Pharma Holdings, Inc. | 57237-301 |
| Senna Syrupsennosides | Sennosides 8.8 mg/5mL | LiquidOral | Rising Pharma Holdings, Inc. | 57237-310 |